Global Drugs Based on CAR T-cell market growth is projected to reach  US$ 6439 million in 2025 to US$ 32570 million in 2031; it is expected to grow at a CAGR of 31.0% from 2025 to 2031.

Global Drugs Based on CAR T-cell Market Trends and Analysis 2025-31

The global Drugs Based on CAR T-cell market size is predicted to grow from US$ 6439 million in 2025 to US$ 32570 million in 2031; it is expected to grow at a CAGR of 31.0% from 2025 to 2031. Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patients own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments. LPI (LP Information) newest research report, the Drugs Based on CAR T-cell Industry Forecast looks at past sales and reviews total world Drugs Based on CAR T-cell sales in 2024, providing a comprehensive analysis by region and market sector of projected Drugs Based on CAR T-cell sales for 2025 through 2031. With Drugs Based on CAR T-cell sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs Based on CAR T-cell industry. This Insight Report provides a comprehensive analysis of the global Drugs Based on CAR T-cell landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drugs Based on CAR T-cell portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Drugs Based on CAR T-cell market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs Based on CAR T-cell and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs Based on CAR T-cell. This report presents a comprehensive overview, market shares, and growth opportunities of Drugs Based on CAR T-cell market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; CD19-targeted &nbsp;&nbsp;&nbsp; BCMA-targeted Segmentation by Application: &nbsp;&nbsp;&nbsp; Lymphoma &nbsp;&nbsp;&nbsp; Multiple Myeloma This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Gilead Sciences &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb &nbsp;&nbsp;&nbsp; J & J &nbsp;&nbsp;&nbsp; JW Therapeutics &nbsp;&nbsp;&nbsp; FOSUNKite

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Drugs Based on CAR T-cell Market Size (2020-2031) &nbsp;2.1.2 Drugs Based on CAR T-cell Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Drugs Based on CAR T-cell by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Drugs Based on CAR T-cell Segment by Type &nbsp;2.2.1 CD19-targeted &nbsp;2.2.2 BCMA-targeted &nbsp;2.3 Drugs Based on CAR T-cell Market Size by Type &nbsp;2.3.1 Drugs Based on CAR T-cell Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Drugs Based on CAR T-cell Market Size Market Share by Type (2020-2025) &nbsp;2.4 Drugs Based on CAR T-cell Segment by Application &nbsp;2.4.1 Lymphoma &nbsp;2.4.2 Multiple Myeloma &nbsp;2.5 Drugs Based on CAR T-cell Market Size by Application &nbsp;2.5.1 Drugs Based on CAR T-cell Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Drugs Based on CAR T-cell Market Size Market Share by Application (2020-2025) 3 Drugs Based on CAR T-cell Market Size by Player &nbsp;3.1 Drugs Based on CAR T-cell Market Size Market Share by Player &nbsp;3.1.1 Global Drugs Based on CAR T-cell Revenue by Player (2020-2025) &nbsp;3.1.2 Global Drugs Based on CAR T-cell Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Drugs Based on CAR T-cell Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Drugs Based on CAR T-cell by Region &nbsp;4.1 Drugs Based on CAR T-cell Market Size by Region (2020-2025) &nbsp;4.2 Global Drugs Based on CAR T-cell Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Drugs Based on CAR T-cell Market Size Growth (2020-2025) &nbsp;4.4 APAC Drugs Based on CAR T-cell Market Size Growth (2020-2025) &nbsp;4.5 Europe Drugs Based on CAR T-cell Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Drugs Based on CAR T-cell Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Drugs Based on CAR T-cell Market Size by Country (2020-2025) &nbsp;5.2 Americas Drugs Based on CAR T-cell Market Size by Type (2020-2025) &nbsp;5.3 Americas Drugs Based on CAR T-cell Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Drugs Based on CAR T-cell Market Size by Region (2020-2025) &nbsp;6.2 APAC Drugs Based on CAR T-cell Market Size by Type (2020-2025) &nbsp;6.3 APAC Drugs Based on CAR T-cell Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Drugs Based on CAR T-cell Market Size by Country (2020-2025) &nbsp;7.2 Europe Drugs Based on CAR T-cell Market Size by Type (2020-2025) &nbsp;7.3 Europe Drugs Based on CAR T-cell Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Drugs Based on CAR T-cell by Region (2020-2025) &nbsp;8.2 Middle East & Africa Drugs Based on CAR T-cell Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Drugs Based on CAR T-cell Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Drugs Based on CAR T-cell Market Forecast &nbsp;10.1 Global Drugs Based on CAR T-cell Forecast by Region (2026-2031) &nbsp;10.1.1 Global Drugs Based on CAR T-cell Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Drugs Based on CAR T-cell Forecast &nbsp;10.1.3 APAC Drugs Based on CAR T-cell Forecast &nbsp;10.1.4 Europe Drugs Based on CAR T-cell Forecast &nbsp;10.1.5 Middle East & Africa Drugs Based on CAR T-cell Forecast &nbsp;10.2 Americas Drugs Based on CAR T-cell Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Drugs Based on CAR T-cell Forecast &nbsp;10.2.2 Canada Market Drugs Based on CAR T-cell Forecast &nbsp;10.2.3 Mexico Market Drugs Based on CAR T-cell Forecast &nbsp;10.2.4 Brazil Market Drugs Based on CAR T-cell Forecast &nbsp;10.3 APAC Drugs Based on CAR T-cell Forecast by Region (2026-2031) &nbsp;10.3.1 China Drugs Based on CAR T-cell Market Forecast &nbsp;10.3.2 Japan Market Drugs Based on CAR T-cell Forecast &nbsp;10.3.3 Korea Market Drugs Based on CAR T-cell Forecast &nbsp;10.3.4 Southeast Asia Market Drugs Based on CAR T-cell Forecast &nbsp;10.3.5 India Market Drugs Based on CAR T-cell Forecast &nbsp;10.3.6 Australia Market Drugs Based on CAR T-cell Forecast &nbsp;10.4 Europe Drugs Based on CAR T-cell Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Drugs Based on CAR T-cell Forecast &nbsp;10.4.2 France Market Drugs Based on CAR T-cell Forecast &nbsp;10.4.3 UK Market Drugs Based on CAR T-cell Forecast &nbsp;10.4.4 Italy Market Drugs Based on CAR T-cell Forecast &nbsp;10.4.5 Russia Market Drugs Based on CAR T-cell Forecast &nbsp;10.5 Middle East & Africa Drugs Based on CAR T-cell Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Drugs Based on CAR T-cell Forecast &nbsp;10.5.2 South Africa Market Drugs Based on CAR T-cell Forecast &nbsp;10.5.3 Israel Market Drugs Based on CAR T-cell Forecast &nbsp;10.5.4 Turkey Market Drugs Based on CAR T-cell Forecast &nbsp;10.6 Global Drugs Based on CAR T-cell Forecast by Type (2026-2031) &nbsp;10.7 Global Drugs Based on CAR T-cell Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Drugs Based on CAR T-cell Forecast 11 Key Players Analysis &nbsp;11.1 Novartis &nbsp;11.1.1 Novartis Company Information &nbsp;11.1.2 Novartis Drugs Based on CAR T-cell Product Offered &nbsp;11.1.3 Novartis Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Novartis Main Business Overview &nbsp;11.1.5 Novartis Latest Developments &nbsp;11.2 Gilead Sciences &nbsp;11.2.1 Gilead Sciences Company Information &nbsp;11.2.2 Gilead Sciences Drugs Based on CAR T-cell Product Offered &nbsp;11.2.3 Gilead Sciences Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Gilead Sciences Main Business Overview &nbsp;11.2.5 Gilead Sciences Latest Developments &nbsp;11.3 Bristol-Myers Squibb &nbsp;11.3.1 Bristol-Myers Squibb Company Information &nbsp;11.3.2 Bristol-Myers Squibb Drugs Based on CAR T-cell Product Offered &nbsp;11.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Bristol-Myers Squibb Main Business Overview &nbsp;11.3.5 Bristol-Myers Squibb Latest Developments &nbsp;11.4 J & J &nbsp;11.4.1 J & J Company Information &nbsp;11.4.2 J & J Drugs Based on CAR T-cell Product Offered &nbsp;11.4.3 J & J Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 J & J Main Business Overview &nbsp;11.4.5 J & J Latest Developments &nbsp;11.5 JW Therapeutics &nbsp;11.5.1 JW Therapeutics Company Information &nbsp;11.5.2 JW Therapeutics Drugs Based on CAR T-cell Product Offered &nbsp;11.5.3 JW Therapeutics Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 JW Therapeutics Main Business Overview &nbsp;11.5.5 JW Therapeutics Latest Developments &nbsp;11.6 FOSUNKite &nbsp;11.6.1 FOSUNKite Company Information &nbsp;11.6.2 FOSUNKite Drugs Based on CAR T-cell Product Offered &nbsp;11.6.3 FOSUNKite Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 FOSUNKite Main Business Overview &nbsp;11.6.5 FOSUNKite Latest Developments 12 Research Findings and Conclusion

Report	Global Drugs Based on CAR T-cell Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI13688

Buyer Information

Order Summary